A young biotech company does not have many opportunities to get things right. Therefore, solutions must be workable, strategic and based upon practical experience and knowledge of the business or product development issues.

Start-up and young companies need unique business and technical advice targeted to their particular development stage.   Our staff  has personally experienced and worked through these challenges at all stages of company and product development.  As a result, we  are able to provide strategic guidance and assistance tailored to your specific growth and development needs.

BioSource Consulting has over 27 years of biotechnology industry experience spanning the scientific to the operational, marketing and strategic business functions.  The principal consultant has led several organizations in various capacities including CEO.  He has been a co-founder of three start-up companies and was trained at one of the largest and most successful biotechnology firms in the industry.  He brings practical insight in the breadth of issues faced by the client-partners he serves.

Biotechnology start-ups and development-stage companies encounter a combination of business, scientific and market development issues. A biotechnology company is a merging of science and business and therefore produces a business of uncertainty. We have experience in the many different facets of the biotechnology industry such as biologics, vaccines, therapeutics, medical devices, molecular diagnostics, point-of-care tests and laboratory-developed testing services. The clients we serve have benefited from our expertise in these industries along with our practical experience at different stages of company development.

BioSource Consulting brings this diverse background expertise to each client-partner we serve.

President & CEO

Dr. Shimasaki has over 27 years of practical experience in the biotechnology industry and as a serial entrepreneur and cofounder of three biotech companies.  Within these companies he has held a variety of positions, including CEO, Chief Operating Officer, VP of Operations, Executive VP of Research and Director of Project Planning. He has raised multiple rounds of capital, both private and public and has been involved in most every facet of a biotech start-up.

He is intimately familiar with the scientific and technical challenges of product development, and he has led international clinical testing and regulatory approval processes for multiple products through the FDA. He has raised multiple rounds of capital for these companies, and directed the marketing strategy and launch of several products developed for molecular testing and personalized medicine.

He is an inventor of numerous patents for both diagnostic and therapeutic applications. His passion is for the establishment and growth of biotechnology companies focused on developing life-saving products that significantly impact the health and well being of others.

Dr. Shimasaki has served or servers on the boards of:  i2E (Innovation to Enterprise) a non-profit technology commercialization center focused on assisting the entrepreneur in taking their ideas through to commercialization; OKBio, the state biotechnology industry organization; and the Governor’s Science and Technology Council.

He received his B.S. in Biochemistry from the University of California at Davis and his Ph.D. in Molecular Biology and Biotechnology from the University of Tulsa and his M.B.A. from Northwestern University’s Kellogg School of Business.